Home
HomeChat
Markets
AlertsCalendarScreenerCharts
Portfolio
WatchlistsPortfolioFiles
Account
Docs
Sign upJoinLog inLogin

Bullfrog AI Holdings, Inc. (BFRG) stock profile

BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.

Key facts

SymbolBFRG
ExchangeNASDAQ
SectorHealthcare
IndustryMedical - Healthcare Information Services
CEOVininder Singh
Employees4
HeadquartersGaithersburg, MD, US
IPO2023-02-13
Websitewww.bullfrogai.com

Explore BFRG on Vantafin

  • Bullfrog AI Holdings, Inc. Overview
  • Bullfrog AI Holdings, Inc. Financials
  • Bullfrog AI Holdings, Inc. News
  • Bullfrog AI Holdings, Inc. Events
  • Bullfrog AI Holdings, Inc. SEC filings
  • Bullfrog AI Holdings, Inc. Insider transactions

Frequently asked questions

What does Bullfrog AI Holdings, Inc. (BFRG) do?
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
Where is BFRG stock listed?
Bullfrog AI Holdings, Inc. trades under the ticker BFRG on NASDAQ.
How can I research BFRG's financials and filings?
Vantafin provides Bullfrog AI Holdings, Inc.'s income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the BFRG profile.